
Noble E. Jarrell
Examiner (ID: 14167, Phone: (571)272-9077 , Office: P/1625 )
| Most Active Art Unit | 1699 |
| Art Unit(s) | 1625, 1699, 1622, 1624, 1609 |
| Total Applications | 1419 |
| Issued Applications | 950 |
| Pending Applications | 180 |
| Abandoned Applications | 334 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16696618
[patent_doc_number] => 10947198
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents
[patent_app_type] => utility
[patent_app_number] => 16/549337
[patent_app_country] => US
[patent_app_date] => 2019-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26558
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16549337
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/549337 | Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents | Aug 22, 2019 | Issued |
Array
(
[id] => 15556633
[patent_doc_number] => 20200062728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => QUINOLINE-BASED COMPOUNDS AND METHODS OF INHIBITING CDK8/19
[patent_app_type] => utility
[patent_app_number] => 16/547350
[patent_app_country] => US
[patent_app_date] => 2019-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16547350
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/547350 | Quinoline-based compounds and methods of inhibiting CDK8/19 | Aug 20, 2019 | Issued |
Array
(
[id] => 16841637
[patent_doc_number] => 11013696
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-25
[patent_title] => Lipids and lipid compositions for the delivery of active agents
[patent_app_type] => utility
[patent_app_number] => 16/537934
[patent_app_country] => US
[patent_app_date] => 2019-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 60263
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16537934
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/537934 | Lipids and lipid compositions for the delivery of active agents | Aug 11, 2019 | Issued |
Array
(
[id] => 19922911
[patent_doc_number] => 12297181
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Methods to chemically modify cannabinoids
[patent_app_type] => utility
[patent_app_number] => 17/267279
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 6092
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/267279 | Methods to chemically modify cannabinoids | Aug 8, 2019 | Issued |
Array
(
[id] => 16896553
[patent_doc_number] => 11038116
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Compound and organic thin film and thin film transistor and electronic device
[patent_app_type] => utility
[patent_app_number] => 16/531376
[patent_app_country] => US
[patent_app_date] => 2019-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12523
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16531376
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/531376 | Compound and organic thin film and thin film transistor and electronic device | Aug 4, 2019 | Issued |
Array
(
[id] => 17183757
[patent_doc_number] => 20210330642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => METHOD FOR TREATING CANCER BY COMBINATION OF IAP INHIBITOR AND MODULATOR OF IMMUNE CHECKPOINT MOLECULE
[patent_app_type] => utility
[patent_app_number] => 16/618792
[patent_app_country] => US
[patent_app_date] => 2019-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16618792
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/618792 | Method for treating cancer by combination of IAP inhibitor and modulator of immune checkpoint molecule | Jul 29, 2019 | Issued |
Array
(
[id] => 15035399
[patent_doc_number] => 20190328704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => SUPER-OXIDE DISMUTASE MIMETICS
[patent_app_type] => utility
[patent_app_number] => 16/509131
[patent_app_country] => US
[patent_app_date] => 2019-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16509131
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/509131 | SUPER-OXIDE DISMUTASE MIMETICS | Jul 10, 2019 | Abandoned |
Array
(
[id] => 17784631
[patent_doc_number] => 11407743
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Amphiphilic and mesogenic organic dyes for tailor-made reflective low-dimensional materials
[patent_app_type] => utility
[patent_app_number] => 17/257031
[patent_app_country] => US
[patent_app_date] => 2019-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 26
[patent_no_of_words] => 18015
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 690
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257031
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257031 | Amphiphilic and mesogenic organic dyes for tailor-made reflective low-dimensional materials | Jul 4, 2019 | Issued |
Array
(
[id] => 18158735
[patent_doc_number] => 20230025327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => CONJUGATES OF TUBULYSIN DERIVATIVES AND CELL BINDING MOLECULES AND METHODS OF MAKING
[patent_app_type] => utility
[patent_app_number] => 17/623360
[patent_app_country] => US
[patent_app_date] => 2019-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17623360
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/623360 | CONJUGATES OF TUBULYSIN DERIVATIVES AND CELL BINDING MOLECULES AND METHODS OF MAKING | Jun 28, 2019 | Pending |
Array
(
[id] => 16141319
[patent_doc_number] => 10703720
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Method for preparing chromium(III) pyridine-2-carboxylate using 2-OP rectification residues
[patent_app_type] => utility
[patent_app_number] => 16/452488
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3124
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16452488
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/452488 | Method for preparing chromium(III) pyridine-2-carboxylate using 2-OP rectification residues | Jun 24, 2019 | Issued |
Array
(
[id] => 16310737
[patent_doc_number] => 20200289475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => RILUZOLE PRODRUGS AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/449948
[patent_app_country] => US
[patent_app_date] => 2019-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16449948
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/449948 | Riluzole prodrugs and their use | Jun 23, 2019 | Issued |
Array
(
[id] => 16525210
[patent_doc_number] => 20200399290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => NANOCOMPOSITE CONTAINING HOLLOW SILICA SPHERES FUNCTIONALIZED WITH AZOLE SILANES
[patent_app_type] => utility
[patent_app_number] => 16/448469
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8353
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16448469
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/448469 | Nanocomposite containing hollow silica spheres functionalized with azole silanes | Jun 20, 2019 | Issued |
Array
(
[id] => 17082044
[patent_doc_number] => 20210277050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => OPHTHALMIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/250281
[patent_app_country] => US
[patent_app_date] => 2019-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12701
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17250281
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/250281 | OPHTHALMIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISORDERS | Jun 17, 2019 | Abandoned |
Array
(
[id] => 15290531
[patent_doc_number] => 20190388401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => RAPAMYCIN ANALOGS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/443298
[patent_app_country] => US
[patent_app_date] => 2019-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16443298
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/443298 | Rapamycin analogs and uses thereof | Jun 16, 2019 | Issued |
Array
(
[id] => 14963021
[patent_doc_number] => 20190308988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => OPIOID RECEPTOR ANTAGONIST PRODRUGS
[patent_app_type] => utility
[patent_app_number] => 16/440988
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16440988
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/440988 | Opioid receptor antagonist prodrugs | Jun 13, 2019 | Issued |
Array
(
[id] => 15383687
[patent_doc_number] => 10533015
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-01-14
[patent_title] => Opioid receptor antagonist prodrugs
[patent_app_type] => utility
[patent_app_number] => 16/440989
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 57496
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16440989
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/440989 | Opioid receptor antagonist prodrugs | Jun 13, 2019 | Issued |
Array
(
[id] => 15327443
[patent_doc_number] => 20200004051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => COLOR VISION CORRECTION FILTER AND OPTICAL COMPONENT
[patent_app_type] => utility
[patent_app_number] => 16/441407
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8332
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16441407
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/441407 | Color vision correction filter and optical component | Jun 13, 2019 | Issued |
Array
(
[id] => 15338801
[patent_doc_number] => 10525055
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Opioid receptor antagonist prodrugs
[patent_app_type] => utility
[patent_app_number] => 16/440985
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 59900
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16440985
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/440985 | Opioid receptor antagonist prodrugs | Jun 13, 2019 | Issued |
Array
(
[id] => 15422481
[patent_doc_number] => 10544154
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Opioid receptor antagonist prodrugs
[patent_app_type] => utility
[patent_app_number] => 16/440986
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 59752
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16440986
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/440986 | Opioid receptor antagonist prodrugs | Jun 13, 2019 | Issued |
Array
(
[id] => 17126096
[patent_doc_number] => 20210300864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => PHOTOSTABILIZING COMPOUNDS, COMPOSITIONS, AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/254207
[patent_app_country] => US
[patent_app_date] => 2019-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17254207
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/254207 | Photostabilizing compounds, compositions, and methods | Jun 12, 2019 | Issued |